Evommune updates corporate presentation (Sept 2026); filing lacks extractable figures

Evommune, Inc.

Evommune (EVMN) posted an updated corporate presentation dated September 15, 2026 on its IR website.
The furnished presentation exhibit was not included in the filing excerpt; no pipeline, financial, or guidance figures are available.
No earnings, deal, or clinical announcements are contained in the 8-K body.
Report signed by President and CEO Luis Peña; disclosure is routine and procedural in nature.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.